PREVIOUS
✖
Itolizumab
July 13 , 2020
1600 days
870
0
- The Drug Controller General of India (DCGI) has given its approval to ‘Itolizumab’ injection.
- It is for the treatment of COVID-19 patients with restricted emergency use only in case of moderate to severe Acute Respiratory Distress Syndrome (ARDS) patients.
- Bengaluru based biopharmaceutical company - Biocon Limited is the developer and the manufactures of the Itolizumab injection.
Leave a Reply
Your Comment is awaiting moderation.